20 miliardi di euro l’anno: i costi per il cancro in Italia – Prevenzione attiva, la vera arma vincente
The missing element is the normality indices that can allow the technology to be used on healthy people to produce sensibly accurate data at levels close to normality. The study proposed by BIOSCIENCE GENOMICS associates the different stages of colon cancer carcinogenesis, starting from the negative value up to stage 1 of colon cancer, with the physiological driver conditions already known and analyzed by HELIXAFE (systemic inflammation, gut bacterial imbalance, genomic instability and immune system deficiency) by adding the analysis of mitochondrial toxicity. This study will allow us to eliminate the gap represented by the current lack of a normal mitochondrial function index.
